Michael Rosenblatt

Michael Rosenblatt

Président chez
Perspectum Ltd.

Fortune : - $ au 31/07/2026

78 ans
Health Technology
Health Services
Consumer Services

Profil

Michael A. Rosenblatt was the founder of Theracrine, Inc., founded in 2006, and Radius Health, Inc., founded in 2003 where the title held was Director.
Current jobs include Executive Chairman at Perspectum Ltd. starting in 2026; Director at Ferring Pharmaceuticals, Inc. since 2016; Director at Cygnal Therapeutics, Inc. since 2016; Director at Perspectum Group Ltd. since 2022; Advisor at PureTech Health LLC; and Senior Advisor at Flagship Pioneering, Inc. since 2016.
Former jobs include Non-Executive Director at Shire Plc from 2008 to 2009; Director at ProScript, Inc.; Director at Project HOPE-The-People-To-People Health Foundation, Inc.; Director at Harvard Mit Health Sciences & Technology in 1998; Independent Director at Axcella Health, Inc. from 2022 to 2023; Independent Director at Rubius Therapeutics, Inc. from 2014 to 2023; Non-Executive Director at PYC Therapeutics Ltd. from 2021 to 2025; Director at Ohana Biosciences, Inc.; Director at Cobalt Biomedicine, Inc.; Independent Director at Azenta, Inc. from 2018 to 2025; Chief Medical Officer & Executive Vice President at Merck & Co., Inc. from 1984 to 2016; Chief Medical Officer at Schering-Plough Corp.; Principal at The General Hospital Corp.
from 1981 to 1984; Senior Vice President-Academic Programs at CareGroup, Inc. in 2000; President at Beth Israel Deaconess Medical Center, Inc. from 1996 to 2003; Member-Scientific Counselors Board at National Institute of Diabetes & Digestive & Kidney Diseases; Senior Vice President-Research at Merck Research Laboratories Massachusetts LLC; Professor at Harvard Medical School; Senior Vice President-Research at Merck Sharp & Dohme Corp.
in 1992; Professor at Molecular Medicine LLC; and Dean at Tufts University School of Medicine.
Education includes undergraduate degree from The Trustees of Columbia University in The City of New York and doctorate from Harvard Medical School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/06/2025 0 ( -.--% ) - $ 31/07/2026

Postes actifs de Michael Rosenblatt

SociétésPosteDébut
Corporate Officer/Principal 29/12/2010
Directeur/Membre du Conseil 01/01/2016
Consultant / Advisor 01/01/2022
Président 07/01/2026
Directeur/Membre du Conseil 25/02/2022
Directeur/Membre du Conseil 01/01/2016

Anciens postes connus de Michael Rosenblatt

SociétésPosteFin
PYC THERAPEUTICS LIMITED Directeur/Membre du Conseil 22/09/2025
AZENTA, INC. Directeur/Membre du Conseil 30/01/2025
AXCA HEALPAR Directeur/Membre du Conseil 01/11/2023
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Michael Rosenblatt

Formation de Michael Rosenblatt

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

79

Relations au 1er degré

31

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées31

Health Technology

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Services

Finance

Health Technology

Health Technology

Finance

Commercial Services

Health Services

Health Technology

Health Services

Government

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Services

Molecular Medicine LLC

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Technology Services

  1. Bourse
  2. Insiders
  3. Michael Rosenblatt